6533b7dbfe1ef96bd1270aaf
RESEARCH PRODUCT
Primordial odontogenic tumor: An immunohistochemical profile.
Ronell Bologna-molinaAdalberto Mosqueda-taylorRoman Carlos-bregniToshinari MikamiVanesa Pereira-pradoF R Piressubject
Male0301 basic medicinePathologymedicine.medical_specialtyAdolescentAntibodies NeoplasmOdontogenic TumorsVimentinHistogenesisRADIOGRAFIA03 medical and health sciences0302 clinical medicineprimordial.medicineHumansPTENDental papillaGeneral DentistryJaw tumorsOral Medicine and PathologybiologyTUMORES ODONTOGENICOSNEOPLASIAS MAXILOMANDIBULARESResearchMesenchymal stem cellodontogenicEnamel organOdontogenic tumorEndoglin:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseImmunohistochemistryJaw Neoplasms030104 developmental biologyOtorhinolaryngologyChild Preschool030220 oncology & carcinogenesisUNESCO::CIENCIAS MÉDICASbiology.proteinFemaleSurgerydescription
Background Primordial Odontogenic Tumor (POT) is a recently described odontogenic tumor characterized by a variably cellular loose fibrous tissue with areas similar to the dental papilla, covered by cuboidal to columnar epithelium that resembles the internal epithelium of the enamel organ, surrounded at least partly by a delicate fibrous capsule. The purpose of this study was to investigate the possible histogenesis and biological behavior of this rare tumor by means of a wide immunohistochemical analysis of its epithelial and mesenchymal components. Material and Methods The immunoexpression of twenty-three different antibodies were evaluated in four cases of POT. Results The epithelial cells that cover the periphery of the tumor showed immunopositivity for Cytokeratins 14 and 19, while Amelogenin, Glut-1, MOC-31, Caveolin-1. Galectin-3, PITX2, p53, Bax, Bcl-2, Survivin and PTEN were variably expressed in focal areas. The mesenchymal component of the tumor was positive for Vimentin, Syndecan-1, PITX2, Endoglin (CD105), CD 34, Cyclin D1, Bax, Bcl-2, Survivin and p53. PTEN and CD 90 showed a moderate positivity. BRAF V600E and Calretinin were negative in all samples. Cell proliferation markers (Ki-67, MCM-7) were expressed in <5% of the tumor cells. Conclusions According to these immunohistochemical findings, we may conclude that POT is a benign odontogenic tumor in which there is both epithelial and mesenchymal activity during its histogenesis, as there is expression of certain components in particular zones in both tissues that suggests this tumor develops during the immature (primordial) stage of tooth development, leading to its inclusion within the group of benign mixed epithelial and mesenchymal odontogenic tumours in the current World Health Organization classification of these lesions. Key words:Immunohistochemistry, jaw tumors, odontogenic, primordial.
year | journal | country | edition | language |
---|---|---|---|---|
2017-02-13 |